Showing 51 - 60 of 265
  • 12 March, 2018 - 11:47
    Aseptika and Zenzium Win Innovate UK funding to build Artificial Intelligence (AI) into Apps and Medical Wearables
    Aseptika and Zenzium Win Innovate UK funding to build Artificial Intelligence (AI) into Apps and Medical Wearables: supporting patients with respiratory disease

    Monday 12th March 2018, St Ives, Cambridgeshire: Aseptika and Zenzium, Ltd., have been awarded a grant from the UK’s innovation agency to develop a new home-based early warning system for people with severe respiratory disease. Artificial Intelligence (AI) will automatically analyse and learn from data generated by the patient at home, using easy-to-use medical monitors and wearables, which connect to Aseptika’s Activ8rlives App.

    “You have a 75% chance of becoming ill in 7 days. You need to ask for help and start taking your Rescue Pack.”

    This will be the level of expertise available to patients that self-care at home that suffer from severe respiratory disease when AI is combined with the latest connected home-use medical monitors and wearables to avoid having to go to hospital.

    The Winter of 2017-2018 will be remembered as the time the NHS treated a record number of patients in its A&E departments. Planning for this was extensive, but demand outstripped supply and NHS frontline staff worked around the clock, prompting new calls to find solutions for the challenges in providing health and social care for an ageing population.

    The challenge for many patients that have long-term health conditions is knowing when to act and to act sooner. Being able to tell the difference between a “bad day” due to the cold weather and the start of life-threatening exacerbation can be a problem for many patients. 

    Acting earlier means that an exacerbation can be controlled with steroids and/or antibiotics in “rescue packs” that patients are issued with to keep at home for emergencies. All too often, patients start using their rescue packs too late and their health deteriorates quickly. Many patients admitted as an emergency this winter, were suffering from respiratory conditions set-off by the winter flu.

    Aseptika and Zenzium will work together to create a system to automatically warn when the patients health is declining. Looking at anonymised information gathered from previous clinical trials showed that many patients do not treat exacerbations and may not even be aware that they are having them. Some perhaps delay treatment hoping that things will get better by themselves. The inflammation of lung tissue during an exacerbation leads to irreversible damage. Over time and after repeated cycles, patients develop shortness of breath and even more opportunities for infections to take hold, in a downward spiral.

    With funding from Innovate UK, the two companies will develop a series of mathematical algorithms, which could be used to prewarn patients of the start of an exacerbation process and to give a risk score for predicted severity to urge earlier action. These patterns are different for each patient but are often repeated. These will be automatically analysed to give a personal detection score that will be continually updated as it learns about each patient and contributes this knowledge to evolve its understanding of these conditions.

    The Companies will introduce this Smart LungHealth system in the form of the Cloud-connecting Activ8rlives4 App and will also embed the AI alerting system into Aseptika’s future wearable medical monitor called the BuddyWOTCH, currently in development.
  • 12 March, 2018 - 08:50
    Differentiated Vs. Incremental Innovation – Are you Focusing on your Customers?
    We often talk about incremental innovation or radical innovation, but what about the spectrum that lies between and are you really focussing on your customers?
    Join ideasUK and Wazoku on Thursday 22 March 9:00 GMT/13:00 GST for a 30 minute online webinar to:
    • Get familiar with the innovation spectrum and the different types of innovation
    • Find out which part of the spectrum your organisation falls into
    • Define differentiated or customer-centric innovation
    • Learn about the advantages of incremental innovation
    • Find out how moving up the innovation spectrum affects the organisational culture 
    Zena Cox, Operations Director, ideasUK
    Rosemarie Diegnan, Chief Strategy & product Officer, Wazoku
    Milena Veneva, Partner Marketing Manager, Wazoku
    To register, click the following link:
  • 12 March, 2018 - 08:45
    Latest NIHR funding calls and other opportunities
    NIHR Health Technology Assessment – Topics for future commissioned calls
    The HTA Programme is considering the below topics for future commissioned research. The likely advert date for these topics, if prioritised, is March 2018. However, please note this is an indicative date, which may change. The commissioning brief, published when the call opens, will provide details of the topic. If you have a comment or question about these potential future research topics, please email
    The HTA Programme is considering the following topics:
    ·         Repair of digital nerve injury
    ·         Microstructural scaffold insertion following microfracture for chondral knee defect
    ·         Paediatric wrist fractures – operate or not?
    ·         Non-operative vs operative management of unstable ankle fractures
    ·         Anticonvulsant augmentation of antipsychotic medication in the management of psychosis
    ·         Routinely used interventions for improving attachment in infants and young children
    ·         Behavioural intervention to treat anxiety in adults with autism and moderate to severe learning disabilities
    ·         Selective serotonin reuptake inhibitor for the treatment of anxiety in adults with autism
    ·         Preventing job loss in people with a long term physical health condition
    ·         Active case finding of coeliac disease in primary care
    ·         Clinical and cost effectiveness of alternative catheter design at preventing catheter-associated urinary tract infection
    ·         Nebulised saline in patients with COPD
    Find out more here.
    NIHR Public Health Research Programme Rapid Funding Scheme
    Details: The Rapid Funding Scheme (RFS) offers researchers the opportunity to apply for funds to conduct rapid baseline data collection, as well as other feasibility work, prior to intervention implementation, for time-limited opportunities such as a natural experiment or similar evaluations of a new public health intervention.
    The RFS has been set up to provide the public health research community with an accelerated route to funding for small-scale, short and time sensitive proposals that demonstrate a need for a rapid commissioning process to be followed. Funding will be offered, subject to appropriate scientific scrutiny, on the understanding that a full application to support completion of the evaluation will be forthcoming at an appropriate time point.
    Application deadline: 31st December 2018
    Find out more here.
    MRC & NRF UK-Kenya Joint Partnership on Non-Communicable Diseases
    Details: The Medical Research Council (MRC) and the National Research Foundation (NRF) of Kenya are pleased to invite research proposals to the Newton Fund’s UK-Kenya Joint Partnership on Non-Communicable Diseases. This initiative will provide funding for high quality collaborative research projects focused on addressing non-communicable diseases (NCDs) in Kenya.
    Deadline for expression of interest: 9th April 2018
    Deadline for proposals: 4pm on 9th May 2018
    Find out more here.

    NIHR Funding deadlines calendar
    For an overview of the year’s NIHR calls and ongoing opportunities, please view the online calendar:
  • 12 March, 2018 - 08:38
    Information Sessions on Funding & Supports // EIT Health UK-Ireland // Startup & Entrepreneur Days
    Rosemary Gallagher, Business Creation Manager for EIT Health UK-Ireland, will be on the road next week promoting the EIT Health Accelerator Call 2018. Please join us for a series of events offering networking, training, and advice. This is a wonderful opportunity to learn more about funding and support initiatives in 2018 and find out how to grow your business, whether you’re a postgraduate student with an idea or an SME ready to explore overseas markets. As many of you have participated in the Accelerator before, please consider inviting a friend along.  
    The EIT Health Accelerator supports business and innovation across Europe. We support every stage of development, from Bootcamps for budding entrepreneurs and funding programmes to help shorten time to market, scale up, and scale out. Applications are now open for the Headstart Funding Programme, where ten worthy companies will be awarded up to €50,000 in the UK Ireland as well as an opportunity to pitch at the International Business Festival in June 2018.
    Come along, say hello, meet successful entrepreneurs and their supporters, and find out what it takes to make your EIT Health Accelerator application stand out from the crowd.
    Register here:
    For more information contact Rosemary Gallagher, Business Creation Manager, EIT Health UK-Ireland []
    Regional Events
    ·      5th March, Newcastle - 12:00 - 15:00
    ·      6th March, London - 16:00 - 18:00
    ·      7th March, Oxford - 18:00 - 20:00
    ·      8th March, Galway - 16:00 - 18:00
    Please note the UK-Ireland Entrepreneur Days will be held at different dates and locations across the UK and Ireland. You can preferred event via the ticket selection. See below for specific information about each regional event.
    5th March, Newcastle - 12:00 - 15:00
    Venue: Newcastle University Research Beehive
    Time: 12-3pm, including lunch
    • Rosemary Gallagher, Business Creation Manager EIT Health: “The EIT Health Accelerator Programmes 2018: supporting businesses from ideation to market”
    • Graham Armitage, Director of Business and Innovation, Newcastle University: “The Newcastle University Innovation Ecosystem”
    • Jerome DeBarros, Innovate UK
    6th March, London - 16:00 - 18:00
    Venue: WeWork Paddington, with refreshments
    Time: 16:00 - 18:00
    • Rosemary Gallagher, Business Creation Manager, EIT Health UK-Ireland
    • Tracey Marriott, Oxford AHSN
    • ...with more to be announced
    7th March, Oxford - 18:00 - 20:00
    Venue: Said Business School, with refreshments
    Time: 18:00 – 20:00
    • Rosemary Gallagher, Business Creation Manager, EIT Health UK-Ireland
    • James Rose, Oxford AHSN
    • ..with more to be announced

    8th March, Galway - 16:00 - 18:00
    Venue: Portershed, Eyre Square, GAlway
    Time: 16:00 - 18:00 followed by MedTech Brew @ Electric Theatre & Garden (separate registration)
    • Rosemary Gallagher, Business Creation Manager, EIT Health UK-Ireland
    • Gillian Buckley, Investment Manager, Western Development Commission
    • Majella Maher, Senior Commercialisation Specialist, Lifescience & Food Commercialisation, Enterprise Ireland
    • Tony O'Halloran & John Thompson, AuriGen Medical - Winners of EIT Health Headstart 2017
  • 2 March, 2018 - 18:37
    Launch of NHS Test Beds - Wave 2
    The second wave of the NHS Test Beds programme has opened for applications, for NHS organisations and industry to bid for funding and support to tackle some of the biggest challenges facing the health service. 

    This is an exciting opportunity for our region to collaborate on an innovative approach to addressing health priorities for the population. 
    Two strands
    There are two strands, with up to £4.5 million available from the Office for Life Sciences for tackling challenges informed by national and local priorities, including: A second strand will allocate up to £1.5 million from NHS England to support Test Beds that tackle a challenge specifically on learning and self-management support for people with Type 2 diabetes. 
    Individual projects will receive between £500,000 and £1.5 million. Small and medium size enterprises will be remunerated for some costs in line with Innovate UK's grant funding rules.

    Who should bid
    Each bid must be led by an NHS provider organisation and should be a partnership between NHS organisations and businesses to solve a specific health and care challenge through a combination of digital products and pathway development, which will be evaluated during the programme.

    We recommend that bidding NHS organisations should seek to directly engage their STP as a connected partner in order to prepare for the eventual adoption and spread of a successful Test Bed.

    Deadline for expression of interest
    The competition is being managed by Innovate UK with an online portal for expressions of interest open until Tuesday 27 March 2018. There are separate expressions of interest portals - for businesses and NHS organisations

    Find out more
    More information about Test Beds Wave 2 is available  here.
    For all queries relating to the competition and the expressions of interest phase, please contact Innovate UK:
    Email -
    Phone - 0300 321 4357

    Feel free to contact the WMAHSN for an informal discussion with one of our senior team, via  

    Matchmaking events
    Academic Health Science Networks are supporting Test Beds Wave 2 and in late Spring we will be organising a series of collaboration workshops around the country, matching businesses with NHS organisations who have applied.
    Shortlisting and final interviews for prospective Test Beds will take place in summer, and successful Test Beds are expected to be announced in September 2018.
  • 26 February, 2018 - 11:19
    Later NIHRt funding calls
    BBSRC ERA-HDHL Call for Transnational Research Proposals: "Nutrition & the Epigenome"
    Details: BBSRC and MRC are supporting UK participation in the JPI HDHL Joint Action on Nutrition and the Epigenome and encourage their research communities to apply for funding as part of transnational consortia. The aim of the call is to support transnational, collaborative research projects that gain a better understanding of the diet-epigenome relationships and their effect on human health. This will allow the development and substantiation of intervention strategies for treating nutrition-related diseases and sustaining good health throughout the life course. BBSRC and MRC will jointly fund the UK partner of successful consortia.
    Application deadline: 16:00 on 12 April 2018
    Find out more here.
    BBSRC New Investigator Scheme
    Details: The BBSRC BBSRC New Investigator Scheme assists early-career researchers – newly employed university lecturers, lecturer level equivalent fellows whose awards were secured in open competition, and researchers in Research Council Institutes at the unified Research Council Band E or its equivalent – to secure their first major element of research funding.
    Application deadline: 16:00 on 24 April 2018
    Find out more here.
    BBSRC Discovery Fellowships
    Details: The BBSRC Discovery Fellowship (DF) will provide support for researchers wishing to undertake independent research and gain leadership skills. The DF will support the transition of early stage researchers to fully independent research leaders. As such DFs represent part of our commitment to the supply of highly skilled professional scientists to the UK. Awards are for three years and it is expected that up to 10 fellowships will be awarded, each of a value of up to £300k (80% fEC). Please note: BBSRC will provide funds of up to £300k (80% of the full economic cost). The total costs (100% full economic cost) requested may be up to £375k.
    Deadline for proposals: 09 May 2018
    Find out more here.
    Arthritis Research UK Starter grants for clinical lecturers
    Details: The starter grants for clinical lecturers scheme provides modest 'starter' funds of up to £30,000 over one to two years to enable research active clinical lecturers pursue their research work, gather preliminary data and so further strengthen their applications for longer term fellowships and funding. This scheme is a partnership between the Academy of Medical Sciences and Arthritis Research UK. Other partners in this scheme include the Wellcome Trust, the British Heart Foundation, the Medical Research Council and Diabetes UK.
    The grants are intended as start-up funding and as such are not intended for applicants who have already obtained substantial funding through, for example, Clinician Scientist Fellowships, New Investigator Awards or large project grants.
    Deadline for proposals: 17:00 on 16 March 2018
    Find out more here.
    Arthritis Research UK Career development fellowship
    Details: Career development fellowships aim to attract and retain talented postdoctoral basic scientists, vets, nurses and allied health professionals in research relevant to arthritis and related musculoskeletal conditions, and provide them with the opportunity to develop an independent research career and progress towards higher-level appointments. Applicants should normally have at least three years’ postdoctoral research experience. Applicants should be associated with an established sponsor, within a multidisciplinary research group in a UK university department, hospital or research institute. Please note, medically or surgically qualified individuals that are practising medicine, aren't eligible to apply for this scheme.
    Deadline for proposals: 16:00 on 11 April 2018
    Find out more here.
    Arthritis Research UK Foundation fellowship
    Details: Foundation fellowships aim to retain the best postdoctoral researchers in areas of research relevant to arthritis and musculoskeletal diseases and provide an opportunity for fellows to develop independent research ideas at an early stage in their career. Foundation fellowships are open to basic science and other non-medical (including nurse and allied health professionals and veterinary surgeons) PhD students in the final year of PhD training, or within one year of completing their PhD at the time of application. These fellowships can't be taken up until the PhD has been awarded. Foundation fellowships should be associated with an established sponsor, within a multidisciplinary research group in a UK university department, hospital or research institute. Please note, medically or surgically qualified individuals that are practising medicine, aren't eligible to apply for this scheme.
    Deadline for proposals: 16:00 on 11 April 2018 
    Find out more here.

    Arthritis Research UK Connect immune research
    Details: Arthritis Research UK, JDRF and the MS Society propose to assist the autoimmunity research community to come together as a consortium to address the common mechanisms underlying immune-mediated inflammatory conditions. The pilot funding shall enable researchers to develop research proposals as a consortium, identifying research questions that can be tackled most effectively by collaborating across different conditions, and setting out how these questions may be answered. By providing these pilot funds it is expected that the consortium will be in a stronger position to apply for longer-term funding from non disease-specific funders such as the MRC, Wellcome, industry, EU and other bodies.
    Deadline for proposals: 16:00 on 19 April 2018
    Find out more here.
    MRC UK-South Africa Joint Initiative on Mental Health
    Details: The health needs of low and middle income countries (LMICs) are evolving with non-communicable diseases (NCDs) now responsible for 40 million deaths per annum (70% of all global deaths). In recognition of this, in 2015 the MRC, the SAMRC, and GSK launched a Joint call on Non-Communicable Diseases in Africa through the Newton Fund. Through this initiative, seven UK-SA collaborative research projects were supported focusing on addressing the burden of cancer, cardiovascular diseases, diabetes, and chronic kidney diseases in Africa.
    The MRC, the Economic and Social Research Council (ESRC) and the South African Medical Research Council (SAMRC) are inviting research proposals to the UK-South Africa mental health initiative. This Newton Fund initiative will provide funding for high quality collaborative research projects focused on addressing mental health in South Africa. In total, up to ~£3.43m/ ZAR 56m over three years will be made available for this initiative.
    Deadline for proposals: 16:00 on 02 May 2018
    Find out more here.
    MRC Senior Clinical Fellowship (SCF) opportunity: April 2018
    Details: The Senior Clinical Fellowship supports talented medically and other clinically qualified professionals, with an effective track record of internationally competitive independent research, to make the transition to research leadership. An SCF provides funding for a challenging research programme, and an ambitious programme of research training which offers accelerated personal and career development.
    Applications are welcome across all areas of the MRC’s remit. Applications may range from basic studies with relevance to mechanisms of disease to translational and developmental clinical research, however, it is expected that applicants’ clinical work will help to inform and strengthen their research work.
    Deadline for proposals: 16:00 on 05 April 2018
    Find out more here.
    MRC Clinician Scientist Fellowship (CSF) opportunity: Apr 2018
    Details: The Clinician Scientist Fellowship develops talented medically and other clinically qualified professionals who have gained a higher research degree to lead their own research plans and establish their own research team to make the transition to independent investigator. Applications are invited for the standard CSFs, the Tenure Track CSFs, or the jointly funded CSFs, all of which are considered in open competition.
    A CSF provides funding for a challenging research programme, and an ambitious programme of research training which offers accelerated personal and career development. Applications are welcome across all areas of the MRC remit.
    Deadline for proposals: 16:00 on 05 April 2018
    Find out more here
    NIHR Funding deadlines calendar
    For an overview of the year’s NIHR calls and ongoing opportunities, please view the online calendar:
  • 23 February, 2018 - 08:53
    Trade Pipeline
    The Life Sciences Organisation (LSO) part of the Department for International Trade (DIT) are developing a trade pipeline. The aim of this is to create a series of asset lists which can be shared across our network. We have developed some for the US, examples of which can be found here We are looking to expand across all sectors, which in addition to the link above will also grow include MedTech, Diabetes, wound care and many more
    To enable us to develop this, we are looking to gather information from UK companies who are, either not currently exporting (but wish to) or those who are currently exporting and wish to explore new markets.  We intend to use this information, in collaboration with our overseas market teams, to match demand (overseas product requirement / collaboration / opportunity) to supply (UK business / company). 
    For us to achieve this we need to capture an overview of company details and to do this I have included a link to a short survey for you to complete; Asset List / Supply Pipeline survey. It is 12 questions and should take no longer than 10 minutes to complete.
     For further details please contact

    Chris Thomas
    Department for International Trade
    Mobile: +44 (0)7471025947
  • 22 February, 2018 - 09:30
    Meridian Celebration of Innovation Awards 2018
    For more infomraiton and the full awards critria click here
  • 21 February, 2018 - 12:01
    EIT Health - summary of SME programmes
    EIT Health has launched its portfolio of programmes for SMEs and is inviting applications. The programmes include proof of concept funding as well as workshops, development programmes and access to coaching and investor networks. A summary of programmes with deadlines and links to additional information for applicants is provided here. Various deadlines apply but the majority are in March- April 2018  
  • 19 February, 2018 - 09:02
    Research Grant & Fellowship Application Training Conference
    The NIHR Clinical Research Network are hosting a West Midlands Training Conference on 27th March in Birmingham focused on success with research grants and fellowships (showcasing NIHR funding schemes, fellowship schemes and how to access support from Patient and Public Involvement, the Research Design Service and registered Clinical Trials Units in the region).

    The programme is available by clicking here, please confirm your place by emailing Debbie Peplow on (places are filling quickly).